For actual fat loss in the belly area, consistency over weeks and months is what produces lasting results
In contrast, Zepbound candidates may have normal or mildly elevated fasting glucose but significant visceral adiposity and metabolic inflammation, requiring longer treatment duration for weight-loss plateaus
Tecentriq (atezolizumab) Disease area(s): Oncology Manufacturer(s): Roche 2024 Sales (USD): $4.13 billion Why it sold so well: In 2024, Roches cancer immunotherapy Tecentriq posted global sales of CHF 3.64 billion ($4.13 billion) and was the companys fourth best-selling drug after MS drug Ocrevus, hemophilia treatment Hemlibra and eye drug Vabysmo
May Enhance Your Athletic Performance If youre an athlete or fitness enthusiast, it can help improve your performance
Parkman HP, Sharkey E, McCallum RW et al (2022) Constipation in patients with symptoms of gastroparesis: analysis of symptoms and gastrointestinal transit